Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 74

1.

Antibiotic-induced decreases in the levels of microbial-derived short-chain fatty acids correlate with increased gastrointestinal colonization of Candida albicans.

Guinan J, Wang S, Hazbun TR, Yadav H, Thangamani S.

Sci Rep. 2019 Jun 20;9(1):8872. doi: 10.1038/s41598-019-45467-7.

2.

Probiotics and Prebiotics for the Amelioration of Type 1 Diabetes: Present and Future Perspectives.

Mishra SP, Wang S, Nagpal R, Miller B, Singh R, Taraphder S, Yadav H.

Microorganisms. 2019 Mar 2;7(3). pii: E67. doi: 10.3390/microorganisms7030067. Review.

3.

Prebiotics from acorn and sago prevent high-fat-diet-induced insulin resistance via microbiome-gut-brain axis modulation.

Ahmadi S, Nagpal R, Wang S, Gagliano J, Kitzman DW, Soleimanian-Zad S, Sheikh-Zeinoddin M, Read R, Yadav H.

J Nutr Biochem. 2019 May;67:1-13. doi: 10.1016/j.jnutbio.2019.01.011. Epub 2019 Jan 30.

PMID:
30831458
4.

Exosome proteomic analyses identify inflammatory phenotype and novel biomarkers in African American prostate cancer patients.

Panigrahi GK, Praharaj PP, Kittaka H, Mridha AR, Black OM, Singh R, Mercer R, van Bokhoven A, Torkko KC, Agarwal C, Agarwal R, Abd Elmageed ZY, Yadav H, Mishra SK, Deep G.

Cancer Med. 2019 Mar;8(3):1110-1123. doi: 10.1002/cam4.1885. Epub 2019 Jan 8.

5.

Comparative Microbiome Signatures and Short-Chain Fatty Acids in Mouse, Rat, Non-human Primate, and Human Feces.

Nagpal R, Wang S, Solberg Woods LC, Seshie O, Chung ST, Shively CA, Register TC, Craft S, McClain DA, Yadav H.

Front Microbiol. 2018 Nov 30;9:2897. doi: 10.3389/fmicb.2018.02897. eCollection 2018.

6.

Bi-directional drug-microbiome interactions of anti-diabetics.

Whang A, Nagpal R, Yadav H.

EBioMedicine. 2019 Jan;39:591-602. doi: 10.1016/j.ebiom.2018.11.046. Epub 2018 Dec 13. Review.

7.

Cross-Talk Between Gluten, Intestinal Microbiota and Intestinal Mucosa in Celiac Disease: Recent Advances and Basis of Autoimmunity.

Chander AM, Yadav H, Jain S, Bhadada SK, Dhawan DK.

Front Microbiol. 2018 Nov 1;9:2597. doi: 10.3389/fmicb.2018.02597. eCollection 2018. Review.

8.

Obesity-Linked Gut Microbiome Dysbiosis Associated with Derangements in Gut Permeability and Intestinal Cellular Homeostasis Independent of Diet.

Nagpal R, Newman TM, Wang S, Jain S, Lovato JF, Yadav H.

J Diabetes Res. 2018 Sep 3;2018:3462092. doi: 10.1155/2018/3462092. eCollection 2018.

9.

Human-origin probiotic cocktail increases short-chain fatty acid production via modulation of mice and human gut microbiome.

Nagpal R, Wang S, Ahmadi S, Hayes J, Gagliano J, Subashchandrabose S, Kitzman DW, Becton T, Read R, Yadav H.

Sci Rep. 2018 Aug 23;8(1):12649. doi: 10.1038/s41598-018-30114-4.

10.

TGF-β receptor 1 regulates progenitors that promote browning of white fat.

Wankhade UD, Lee JH, Dagur PK, Yadav H, Shen M, Chen W, Kulkarni AB, McCoy JP, Finkel T, Cypess AM, Rane SG.

Mol Metab. 2018 Oct;16:160-171. doi: 10.1016/j.molmet.2018.07.008. Epub 2018 Jul 27.

11.

Gut microbiome and aging: Physiological and mechanistic insights.

Nagpal R, Mainali R, Ahmadi S, Wang S, Singh R, Kavanagh K, Kitzman DW, Kushugulova A, Marotta F, Yadav H.

Nutr Healthy Aging. 2018 Jun 15;4(4):267-285. doi: 10.3233/NHA-170030. Review.

12.

Gut Microbiome Composition in Non-human Primates Consuming a Western or Mediterranean Diet.

Nagpal R, Shively CA, Appt SA, Register TC, Michalson KT, Vitolins MZ, Yadav H.

Front Nutr. 2018 Apr 25;5:28. doi: 10.3389/fnut.2018.00028. eCollection 2018.

13.

Bacterial Translocation from the Gut to the Distant Organs: An Overview.

Nagpal R, Yadav H.

Ann Nutr Metab. 2017;71 Suppl 1:11-16. doi: 10.1159/000479918. Epub 2017 Sep 28. Review.

PMID:
28950279
14.

Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma.

Khan Z, Khan AA, Yadav H, Prasad GBKS, Bisen PS.

Cell Mol Biol Lett. 2017 Apr 5;22:8. doi: 10.1186/s11658-017-0038-0. eCollection 2017. Review.

15.

Interplay between Oxidative Stress and Metabolism in Signalling and Disease 2016.

Kelley EE, Paes AM, Yadav H, Quijano C, Cassina A, Trostchansky A.

Oxid Med Cell Longev. 2017;2017:7013972. doi: 10.1155/2017/7013972. Epub 2017 Jan 22. No abstract available.

16.

Novel Browning Agents, Mechanisms, and Therapeutic Potentials of Brown Adipose Tissue.

Wankhade UD, Shen M, Yadav H, Thakali KM.

Biomed Res Int. 2016;2016:2365609. doi: 10.1155/2016/2365609. Epub 2016 Dec 25. Review.

17.

TGF-β1/Smad3 Pathway Targets PP2A-AMPK-FoxO1 Signaling to Regulate Hepatic Gluconeogenesis.

Yadav H, Devalaraja S, Chung ST, Rane SG.

J Biol Chem. 2017 Feb 24;292(8):3420-3432. doi: 10.1074/jbc.M116.764910. Epub 2017 Jan 9.

18.

Identification of Guanosine 5'-diphosphate as Potential Iron Mobilizer: Preventing the Hepcidin-Ferroportin Interaction and Modulating the Interleukin-6/Stat-3 Pathway.

Angmo S, Tripathi N, Abbat S, Sharma S, Singh SS, Halder A, Yadav K, Shukla G, Sandhir R, Rishi V, Bharatam PV, Yadav H, Singhal NK.

Sci Rep. 2017 Jan 5;7:40097. doi: 10.1038/srep40097.

19.

A 2-year Double-Blind RCT Follow-up Study with Fermented Papaya Preparation (FPP) Modulating Key Markers in Middle-Age Subjects with Clustered Neurodegenerative Disease-Risk Factors.

Marotta F, Marcellino M, Solimene U, Cuffari B, Yadav H, Khokhlov AN, Lorenzetti A, Mantello A, Cervi J, Catanzaro R.

Clin Pharmacol Biopharm. 2017;6. pii: 170. doi: 10.4172/2167-065X.1000170. Epub 2017 May 18.

20.

PROBIOTICS - A PROBABLE THERAPEUTIC AGENT FOR SPONDYLOARTHROPATHY.

Singh N, Yadav H, Marotta F, Singh V.

Int J Probiotics Prebiotics. 2017;12(2):57-68. Epub 2017 Aug 21.

Supplemental Content

Loading ...
Support Center